ScholarIQanswers from OpenAlex & ORCID
Pablo Tamayo
ResearcherPublications, citations & collaboration network
Pablo Tamayo is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Pablo Tamayo have?
ScholarIQindexed works
Pablo Tamayo has 617 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Pablo Tamayo have?
ScholarIQcitation count
Pablo Tamayo has 160,029 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Pablo Tamayo?
ScholarIQh-index
Pablo Tamayo has an h-index of 83 in OpenAlex.
What is the i10-index of Pablo Tamayo?
ScholarIQi10-index
Pablo Tamayo has an i10-index of 156 in OpenAlex.
What is the ORCID of Pablo Tamayo?
ScholarIQorcid
The ORCID for Pablo Tamayo is on the source record.
What is the OpenAlex record for Pablo Tamayo?
ScholarIQopenalex
The OpenAlex for Pablo Tamayo is on the source record.
What are the most-cited papers on Pablo Tamayo?
ScholarIQmost cited works
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie, Pablo Tamayo, Jesse S. Boehm, So Young Kim, Susan E. Moody, Ian F. Dunn, Anna C. Schinzel, Péter Sandy, Etienne Meylan, Claudia Scholl, Stefan Fröhling, Edmond M. Chan, Martin L. Sos, Kathrin Michel, Craig H. Mermel, Serena J. Silver, Barbara A. Weir, Jan H. Reiling, Qing Sheng, Piyush B. Gupta, Raymond Wadlow, Hanh Le, Sebastian Hoersch, Ben S. Wittner, Sridhar Ramaswamy, David M. Livingston, David M. Sabatini, Matthew Meyerson, Roman K. Thomas, Eric S. Lander, Jill P. Mesirov, David E. Root, D. Gary Gilliland, Tyler Jacks, William C. Hahn
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
Vasanthi S. Viswanathan, Matthew J. Ryan, Harshil Dhruv, Shubhroz Gill, Ossia M. Eichhoff, Brinton Seashore‐Ludlow, Samuel D. Kaffenberger, John K. Eaton, Kenichi Shimada, Andrew J. Aguirre, Srinivas R. Viswanathan, Shrikanta Chattopadhyay, Pablo Tamayo, Wan Seok Yang, Matthew G. Rees, Sixun Chen, Žarko Bošković, Sarah Javaid, Cherrie Huang, Xiaoyun Wu, Yuen‐Yi Tseng, Elisabeth Roider, Dong Gao, James M. Cleary, Brian M. Wolpin, Jill P. Mesirov, Daniel A. Haber, Jeffrey A. Engelman, Jesse S. Boehm, Joanne Kotz, Cindy Hon, Yu Chen, William C. Hahn, Mitchell P. Levesque, John G. Doench, Michael E. Berens, Alykhan F. Shamji, Paul A. Clemons, Brent R. Stockwell, Stuart L. Schreiber
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
Adam J. Bass, Hideo Watanabe, Craig H. Mermel, Soyoung Yu, Sven Perner, Roel G.W. Verhaak, So Young Kim, Leslie Wardwell, Pablo Tamayo, Irit Gat‐Viks, Alex H. Ramos, Michele Sue‐Ann Woo, Barbara A. Weir, Gad Getz, Rameen Beroukhim, Michael O'Kelly, Amit Dutt, Orit Rozenblatt–Rosen, Piotr Dziunycz, Justin Komisarof, Lucian R. Chirieac, Christopher J. Lafargue, Veit Scheble, Theresia Wilbertz, Changqing Ma, Shilpa Rao, Hiroshi Nakagawa, Douglas B. Stairs, Lin Lin, Thomas J. Giordano, Patrick Wagner, John D. Minna, Adi F. Gazdar, Chang‐Qi Zhu, Marcia S. Brose, Ivan Cecconello, Ulysses Ribeiro, Suely Kazue Nagahashi Marie, Olav Dahl, Ramesh A. Shivdasani, Ming‐Sound Tsao, Mark A. Rubin, Kwok‐Kin Wong, Aviv Regev, William C. Hahn, David G. Beer, Anil K. Rustgi, Matthew Meyerson
Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses
Israel Cañadas, Rohit Thummalapalli, Jong Wook Kim, Shunsuke Kitajima, Russell W. Jenkins, Camilla L. Christensen, Marco Campisi, Yanan Kuang, Yanxi Zhang, Evisa Gjini, Gao Zhang, Tian Tian, Debattama R. Sen, Diana Miao, Yu Imamura, Tran C. Thai, Brandon Piel, Hideki Terai, Amir Reza Aref, Timothy Hagan, Shohei Koyama, Masayuki Watanabe, Hideo Baba, Anika E. Adeni, Christine Lydon, Pablo Tamayo, Zhi Wei, Meenhard Herlyn, Thanh U. Barbie, Ravindra Uppaluri, Lynnette Marie Sholl, Ewa Sicińska, Jacob Sands, Scott J. Rodig, Kwok‐Kin Wong, Cloud P. Paweletz, Hideo Watanabe, David A. Barbie